Drug dosing in renal insufficiency

Drug dosing in renal insufficiency needs to be individualized whenever possible to optimize therapeutic outcomes and to minimize toxicity. Although a number of published tables that provide dosing guidelines and nomograms exist to assist in dose modification, individualization of therapy should be based on pharmacokinetic principles whenever possible. The basis equations to estimate the pharmacokinetic parameters of clearance, volume of distribution, and half-life for intravenous drug administration of drugs with first-order kinetics are not difficult to understand and apply. Their use should be encouraged in patient care.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				E. Simard, J. Naud, J. Michaud, F. A. Leblond, A. Bonnardeaux, C. Guillemette, E. Sim, and V. Pichette Downregulation of Hepatic Acetylation of Drugs in Chronic Renal Failure J. Am. Soc. Nephrol., July 1, 2008; 19(7): 1352 - 1359. [Full Text] [PDF]

				J. Naud, J. Michaud, F. A. Leblond, S. Lefrancois, A. Bonnardeaux, and V. Pichette Effects of Chronic Renal Failure on Liver Drug Transporters Drug Metab. Dispos., January 1, 2008; 36(1): 124 - 128. [Abstract] [Full Text] [PDF]

				J. Naud, J. Michaud, C. Boisvert, K. Desbiens, F. A. Leblond, A. Mitchell, C. Jones, A. Bonnardeaux, and V. Pichette Down-Regulation of Intestinal Drug Transporters in Chronic Renal Failure in Rats J. Pharmacol. Exp. Ther., March 1, 2007; 320(3): 978 - 985. [Abstract] [Full Text] [PDF]

				C. L Long, M. A Raebel, D. W Price, and D. J Magid Compliance with Dosing Guidelines in Patients with Chronic Kidney Disease Ann. Pharmacother., May 1, 2004; 38(5): 853 - 858. [Abstract] [Full Text] [PDF]

				F. A. Leblond, M. Petrucci, P. Dube, G. Bernier, A. Bonnardeaux, and V. Pichette Downregulation of Intestinal Cytochrome P450 in Chronic Renal Failure J. Am. Soc. Nephrol., June 1, 2002; 13(6): 1579 - 1585. [Abstract] [Full Text] [PDF]

				E. J. Randinitis, J. R. Koup, G. Rausch, R. Abel, N. J. Bron, N. J. Hounslow, A. B. Vassos, and A. J. Sedman Clinafloxacin Pharmacokinetics in Subjects with Various Degrees of Renal Function Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2536 - 2542. [Abstract] [Full Text] [PDF]

				F. LEBLOND, C. GUÉVIN, C. DEMERS, I. PELLERIN, M. GASCON-BARRÉ, and V. PICHETTE Downregulation of Hepatic Cytochrome P450 in Chronic Renal Failure J. Am. Soc. Nephrol., February 1, 2001; 12(2): 326 - 332. [Abstract] [Full Text]

				F. A. Leblond, L. Giroux, J.-P. Villeneuve, and V. Pichette Decreased in Vivo Metabolism of Drugs in Chronic Renal Failure Drug Metab. Dispos., November 1, 2000; 28(11): 1317 - 1320. [Abstract] [Full Text]